Skip to main content
SpringerLink
Log in

Validated Stability-Indicating HPLC and UPLC Assay Methods for the Determination of Entacapone in Pharmaceutical Dosage Forms

  • Short Communication
  • Published:
Chromatographia Aims and scope Submit manuscript

Abstract

In the present study, new isocratic stability-indicating reverse phase chromatographic methods were developed using HPLC and UPLC systems for the determination of entacapone (ENT) in its pharmaceutical dosage forms. Ultra performance liquid chromatography (UPLC) using small sub-2 μm particles and high-performance liquid chromatography (HPLC) were compared for separation and determination of the ENT using Acquity HSS C18 (50 × 2.1 mm, 1.8 µm) and Xbridge C18 (150 × 4.6 mm, 5.0 µm) columns by UPLC and HPLC, respectively. When using UPLC, the run time could be reduced five fold and actually the solvent consumption decreased 10 times. The proposed UPLC method would decrease the consumption of organic solvents and reagents. The present methods were validated according to ICH guideline. All analytical procedures including sample preparation, flow rate, run time of the analytical systems were at low levels. Forced degradation studies were also performed for both compounds in bulk drug samples to demonstrate the specificity and stability-indicating comparative advantage of both methods.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Paija O, Laine K, Kultalahti ER, Leinonen M, Huupponen R, Gordin A, Reinikainen K (2005) Entacapone increases levodopa exposure and reduces plasma levodopa variability when used with Sinemet CR. Clin Neuropharm 28:115–119

    Article  CAS  Google Scholar 

  2. Mohamed NG, Mohamed MS (2010) Determination of antiparkinsonism drug entacapone. J Chilean Chem Soc 55:85–89

    CAS  Google Scholar 

  3. Paim CS, Gonçalves HML, Miron D, Sippel J, Steppe M (2007) Stability-indication LC determination of entacapone in tablets. Chromatographia 65:595–599

    Article  CAS  Google Scholar 

  4. Paim CS, Martins MT, Malesuik MD, Steppe M (2010) LC determination of entacapone in tablets: in vitro dissolution studies. J Chromatogr Sci 48(9):755–759

    Article  CAS  Google Scholar 

  5. Shetty SK, Surendranath KV, Radhakrishnanand P, Satish J, Jogul J, Tripathi UM (2009) Stress degradation behavior of entacapone and development of LC stability-indicating related substances and assay method. Chromatographia 69:1189–1199

    Article  CAS  Google Scholar 

  6. Soukhova N, Kassymbek Z, Bradby S, Martin-Esker A, White P, Wahab S (2011) Development of characterization methods for entacapone in a pharmaceutical bulk. J Pharm Biomed Anal 54(4):860–865

    Article  CAS  Google Scholar 

  7. Tekale P, Tekale S, Mhatre VS (2011) Development of characterization methods for entacapone in a pharmaceutical bulk. Der Pharm Chem 3:63–68

    CAS  Google Scholar 

  8. Vemic A, Stojanovic BJ, Stamenkovic I, Malenovic A (2013) Chaotropic agents in liquid chromatographic method development for the simultaneous analysis of levodopa, carbidopa, entacapone and their impurities. J Pharm Biomed Anal 77:9–15

    Article  CAS  Google Scholar 

  9. Alagar RM, Shyamsunder C, Banji D, Rao KNV, Kumar SD (2013) Analytical method development and validation for simultaneous estimation of carbidopa, levodopa and entacapone in its bulk and tablet dosage form by UPLC. Int Res J Pharm 4:53–56

    Article  CAS  Google Scholar 

  10. Gumustas M, Kurbanoglu S, Uslu B, Ozkan SA (2013) UPLC versus HPLC on drug analysis: advantageous, applications and their validation parameters. Chromatographia 76: 1365–1427

  11. ICH Guideline (Q2A) (R1) (2005) Validation of analytical procedures: text and methodology

  12. ICH Guideline (Q1AR) (2000) Stability testing of new drug substances and products International Conference on harmonization IFPMA, Geneva

  13. Ozkan SA (2012) Electroanalytical methods in pharmaceutical analysis and their validation, 1st edn. HNB Pub, New York

    Google Scholar 

  14. The United States Pharmacopeia (The USP 32-NF 27) (2009) The Official Compendia of Standards. United States Pharmacopeial Convention, Rockville

    Google Scholar 

  15. Gumustas M, Ozkan SA (2013) A validated stability-indicating RP-LC method for the simultaneous determination of amlodipine and perindopril in tablet dosage form and their stress degradation behavior under ICH-recommended stress conditions. J AOAC Int 96:751–757

    Article  CAS  Google Scholar 

Download references

Conflict of interest

The authors have no conflict of interest to declare.

Author information

Authors and Affiliations

  1. Department of Analytical Chemistry, Faculty of Pharmacy, Ankara University, Ankara, Turkey

    Mehmet Gumustas, Bengi Uslu & Sibel. A. Ozkan

  2. Pharmaceutical and Medicinal Chemistry Department, Pharmaceutical and Drug Industries Research Division, National Research Centre, Dokki, Cairo, 12311, Egypt

    Hassan Y. Aboul-Enein

Authors
  1. Mehmet Gumustas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bengi Uslu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sibel. A. Ozkan
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hassan Y. Aboul-Enein
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bengi Uslu.

Electronic Supplementary Material

Below is the link to the electronic supplementary material.

Supplementary material 1 (PDF 323 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gumustas, M., Uslu, B., Ozkan, S.A. et al. Validated Stability-Indicating HPLC and UPLC Assay Methods for the Determination of Entacapone in Pharmaceutical Dosage Forms. Chromatographia 77, 1721–1726 (2014). https://doi.org/10.1007/s10337-014-2758-x

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10337-014-2758-x

Keywords

Search

Navigation